Yakult Honsha Co Ltd
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|^Ry | LOCK|!jvt | LOCK|?Sc#<&> |
Persistent Headwinds in Domestic Market a Drag on Yakult Honsha's Near-Term Earnings
Business Strategy and Outlook
Research and development in probiotics, primarily in beverage products and pharmaceuticals, has laid the foundation for Yakult Honsha. Its flagship products are probiotic drinks marketed under the namesake brand in 40 countries across four continents, making up an estimated 80% of group sales and 90% of profits. Expanding the international footprint and enhancing domestic profitability through premiumization are the two pillars of Yakult’s growth strategy. Domestic growth lifted by the premium Yakult 1000/Y1000 success has taken up the baton from overseas volume expansion, becoming a key profit driver.
